229 related articles for article (PubMed ID: 11302142)
21. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
22. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
23. High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
Xu W; Miao KR; Hong M; Zhu DX; Fang C; Dong HJ; Wang DM; Cao X; Li JY
Eur J Cancer; 2010 Aug; 46(12):2145-9. PubMed ID: 20627536
[TBL] [Abstract][Full Text] [Related]
24. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
Schirmer M; Michlmayr G; Geisen F; Konwalinka G
Leukemia; 1996 Jul; 10(7):1253-4. PubMed ID: 8684013
[No Abstract] [Full Text] [Related]
25. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
Delannoy A; Hanique G; Ferrant A
N Engl J Med; 1993 Mar; 328(11):812; author reply 813. PubMed ID: 8094888
[No Abstract] [Full Text] [Related]
26. Richter's syndrome--the downside of fludarabine?
Hamblin TJ
Leuk Res; 2005 Oct; 29(10):1103-4. PubMed ID: 16111529
[No Abstract] [Full Text] [Related]
27. [Current concepts in chronic lymphocytic leukemia. Better chances for young patients].
Hallek M; Bergmann M; Goede V; Fingerle-Rowson G; Schweighofer C; Schmitt B; Wendtner CM; Emmerich B
MMW Fortschr Med; 2003 Jul; 145(27-28):46-9. PubMed ID: 14587189
[No Abstract] [Full Text] [Related]
28. Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
Richards S
Cancer Treat Rev; 2005 Jun; 31(4):332-5. PubMed ID: 15894429
[No Abstract] [Full Text] [Related]
29. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Perkins JG; Flynn JM; Howard RS; Byrd JC
Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
[TBL] [Abstract][Full Text] [Related]
30. [Chronic lymphocytic leukemia. 2. Therapy].
Hallek M; Schmitt B; Emmerich B; Stein H
Dtsch Med Wochenschr; 2001 Jun; 126(23):690-5. PubMed ID: 11441667
[No Abstract] [Full Text] [Related]
31. Fludarabine treatment and transfusion-associated graft-versus-host disease.
Saven A
Lancet; 1996 Aug; 348(9025):473. PubMed ID: 8709797
[No Abstract] [Full Text] [Related]
32. [Fludarabine and fatal hemolytic anemia].
López L; del Villar V; Pascual T
Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
[No Abstract] [Full Text] [Related]
33. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
[TBL] [Abstract][Full Text] [Related]
34. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
Lam CC; Ma ES; Kwong YL
Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
Wells T; Kovacs MJ
Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
[TBL] [Abstract][Full Text] [Related]
36. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
37. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
38. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
Saven A; Piro L
N Engl J Med; 1994 Jun; 330(25):1829-30. PubMed ID: 7910665
[No Abstract] [Full Text] [Related]
39. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphocytic leukaemia: only treat when symptomatic.
Prescrire Int; 2002 Oct; 11(61):156-7. PubMed ID: 12378749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]